Mr. Everson, your industry has always been exceptionally supportive when representatives have appeared in front of us because you understand the importance of export, what that means. I won't dwell on the issue of capacity. I think a couple of my colleagues have asked that question. It certainly is clear to me that you've got the ability to do that.
I need some clarity around a couple of things you talked about. You talked about biotechnology in your formal comments. You said that the EU's regulatory system for biotechnology creates risks for exporters and some uncertainty in some aspects of your industry. You've indicated that the EU's regulatory environment creates real barriers to trade in innovation. To what extent does this agreement get around that or the things that can, should, need to be done to support our canola industry?